The company's tight control over patient costs helped it improve
its benefit expense ratio to 83.4 percent from 86.1 percent in
the year-ago period. The figure is widely watched in the sector
because it measures an insurer's expenses on claims against the
premiums it earns.
Last week, larger rival UnitedHealth Group <UNH.N> reported a
benefit expense ratio that missed analysts' estimates,
overshadowing better-than-expected earnings.
In contrast to the debates around UnitedHealth and Centene Corp
<CNC.N> earnings, Anthem's results is a cleaner benefit expense
ratio-driven beat and raise that still includes conservatism for
the second half of the year, Evercore ISI analyst Michael
Newshel said in a note.
Despite solid results, Anthem said medical enrollment fell about
2.2 percent to 39.5 million members at the end of the quarter.
The company, which has cut the number of markets where it will
offer Obamacare individual plans in 2018, said the reduced
footprint as well membership losses in Medicaid led to a decline
in members.
The Trump administration has been issuing new rules and
regulations to roll back some of the insurance coverage
expansion that took place with Obamacare, former President
Barack Obama's 2010 health law.
Anthem said net income rose 23 percent to $1.05 billion, or
$3.98 per share, in the second quarter ended June 30.
Excluding items, the company earned $4.25 per share, ahead of
analysts' average estimate of $4.16, according to Thomson
Reuters I/B/E/S.
Total revenue rose 2.4 percent to $22.94 billion. Operating
revenue was $22.71 billion, compared with the analysts' estimate
of $22.69 billion.
The company said it now expects 2018 adjusted earnings to be
greater than $15.40 per share, up from its previous estimate of
earnings of greater than $15.30 per share.
(Reporting by Ankur Banerjee in Bengaluru; Editing by Bernard
Orr)
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|